Relugolix
Myovant,Pfizer
['nrg-gu011', 'prostate', 'trap', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nrg,promethean', 'relugolix']
nrg-gu011 a phase ii double-blinded, pbo-controlled trial of prostate oligometastatic radiotherapy with or w/o adt in oligometastatic #prostatecancer (nrg promethean). bridget koontz, md . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology